Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Omak › NPI 1255387403
Hospital

Okanogan County Public Hospital District No. 3

Okanogan County Public Hospital District No. 3 was paid $24.19M by Medicaid between Jan 2018 and Dec 2024, across 196 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

33Billing provider infoOKANOGAN COUNTY PUBLIC HOSPITAL DISTRICT NO. 3
OMAK, WA 98841
33aNPI1255387403assigned 05/26/2006
33bProvider typeCritical Access Hospital
28Total paid$24.19M
24GClaims313,483
24DCodes billed196
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Washington

Rank by total paid#6 of 30
Median peer was paid$9.10M
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201839,140$1.89M
201941,455$2.94M
202041,515$3.18M
202147,480$3.43M
202246,975$3.99M
202350,382$4.41M
2024incomplete46,536$4.35M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 24,035 21,531 $4.13M
74177 Computed tomography, abdomen and pelvis; with contrast material 11% 3,309 2,808 $2.58M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.8% 18,413 17,079 $2.14M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.3% 5,384 4,562 $2.02M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3.7% 3,854 3,663 $893K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.6% 11,275 10,658 $635K
70450 Computed tomography, head or brain; without contrast material 2.5% 2,490 2,101 $612K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.5% 6,423 5,445 $606K
G0378 Hospital observation service, per hour 2.4% 937 748 $586K
96361 Intravenous infusion, hydration; each additional hour 2.0% 6,083 4,901 $476K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 3,178 2,602 $462K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.9% 2,848 2,515 $448K
184 more codes
80053 Comprehensive metabolic panel 1.7% 14,872 $420K
96375 Therapeutic injection; each additional sequential IV push 1.5% 5,718 $360K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.4% 5,864 $350K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 14,641 $297K
80050 General health panel 1.1% 3,066 $278K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.1% 706 $277K
87631 1.1% 1,006 $270K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 98 $224K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,810 $224K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,045 $211K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 410 $202K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,042 $194K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,426 $182K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,203 $172K
72125 Computed tomography, cervical spine; without contrast material <1% 431 $169K
83880 <1% 2,005 $157K
83605 <1% 4,993 $153K
71045 Radiologic examination, chest; single view <1% 5,084 $153K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,360 $144K
59025 Fetal non-stress test <1% 895 $141K
84484 <1% 4,871 $140K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,267 $131K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,137 $113K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,137 $111K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 292 $109K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 663 $104K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,714 $103K
83690 <1% 5,190 $101K
71046 Radiologic examination, chest; 2 views <1% 1,654 $95K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 816 $92K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 768 $91K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,073 $91K
96376 <1% 2,327 $87K
36415 Collection of venous blood by venipuncture <1% 12,118 $84K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,334 $78K
81025 <1% 3,719 $78K
87040 <1% 2,504 $72K
82077 <1% 1,636 $71K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,412 $68K
87088 <1% 2,879 $61K
84145 <1% 977 $59K
83735 <1% 3,501 $57K
84443 Thyroid stimulating hormone (TSH) <1% 1,472 $56K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 429 $55K
81003 <1% 7,484 $54K
81001 <1% 6,041 $53K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,480 $53K
87077 <1% 1,925 $52K
85730 <1% 3,445 $51K
93041 <1% 2,279 $50K
82805 <1% 293 $46K
85610 <1% 4,379 $46K
76830 Ultrasound, transvaginal <1% 273 $45K
76801 <1% 294 $45K
94060 <1% 418 $45K
82150 <1% 2,564 $44K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 61 $43K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,471 $42K
71275 Computed tomographic angiography, chest, with contrast material <1% 64 $41K
87186 <1% 1,643 $41K
73610 <1% 381 $40K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,078 $39K
73130 <1% 388 $38K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 315 $37K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 693 $34K
85379 <1% 1,270 $34K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,265 $33K
85027 <1% 2,056 $33K
83036 Hemoglobin; glycosylated (A1C) <1% 1,297 $33K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 838 $31K
97161 <1% 322 $30K
87070 <1% 1,091 $29K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 387 $29K
86140 <1% 2,088 $27K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,395 $26K
84702 <1% 620 $26K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,148 $26K
86850 <1% 630 $25K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 202 $25K
77067 Screening mammography, bilateral, including computer-aided detection <1% 299 $24K
80061 Lipid panel <1% 624 $24K
73110 <1% 200 $23K
J2704 Injection, propofol, 10 mg <1% 1,679 $23K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 925 $22K
73562 <1% 217 $21K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 33 $20K
94729 <1% 155 $19K
90715 <1% 288 $19K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 138 $18K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 104 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 934 $18K
84703 <1% 729 $17K
82248 <1% 1,223 $16K
73030 <1% 178 $15K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 345 $13K
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 206 $13K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 637 $12K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,409 $12K
70486 <1% 25 $11K
73630 <1% 129 $10K
93017 <1% 114 $10K
82948 <1% 660 $10K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $10K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 152 $10K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,309 $10K
J0690 Injection, cefazolin sodium, 500 mg <1% 866 $9K
82550 <1% 524 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 965 $7K
87210 <1% 482 $7K
86901 <1% 685 $7K
C9113 Injection, pantoprazole sodium, per vial <1% 676 $7K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 12 $7K
86900 <1% 594 $6K
76642 <1% 92 $6K
J2270 Injection, morphine sulfate, up to 10 mg <1% 361 $5K
97035 <1% 273 $5K
85651 <1% 552 $5K
87205 <1% 437 $5K
96367 <1% 58 $5K
77063 Screening digital breast tomosynthesis, bilateral <1% 272 $5K
J7050 Infusion, normal saline solution, 250 cc <1% 290 $4K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 111 $4K
87420 <1% 87 $4K
J2060 Injection, lorazepam, 2 mg <1% 387 $4K
71250 <1% 17 $4K
80305 <1% 122 $3K
84439 <1% 148 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 27 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 45 $3K
85007 <1% 271 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 83 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 118 $2K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 39 $2K
J3490 Unclassified drugs <1% 89 $2K
73502 <1% 17 $2K
80320 <1% 2,332 $2K
94726 <1% 13 $2K
80047 <1% 61 $2K
97162 <1% 15 $2K
99213 Doctor's office visit, returning patient (routine) <1% 15 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 76 $1K
82565 <1% 131 $1K
87220 <1% 101 $1K
73560 <1% 16 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 154 $1K
76000 <1% 12 $1K
82570 <1% 69 $1K
12001 <1% 12 $900.51
82140 <1% 20 $875.67
J1171 Injection, hydromorphone, 0.1 mg <1% 45 $787.83
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 189 $717.98
86703 <1% 13 $648.58
36600 <1% 15 $568.61
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 90 $555.24
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 640 $552.14
82247 <1% 36 $539.91
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 74 $523.03
85014 <1% 137 $517.41
87340 <1% 14 $516.24
J3475 Injection, magnesium sulfate, per 500 mg <1% 32 $350.36
93016 <1% 32 $253.06
J2470 Injection, pantoprazole sodium, 40 mg <1% 28 $239.72
82043 <1% 13 $224.16
99238 Hospital discharge day management, 30 minutes or less <1% 13 $214.70
36416 <1% 31 $212.94
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 17 $210.49
93018 <1% 32 $150.92
J2471 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg <1% 29 $140.48
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 13 $139.93
84520 <1% 13 $136.18
J1815 Injection, insulin, per 5 units <1% 14 $134.44
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 15 $129.91
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 13 $121.51
A4215 Needle, sterile, any size, each <1% 497 $114.68
93000 <1% 18 $104.23
84100 <1% 13 $95.94
81015 <1% 71 $85.93
80329 <1% 1,596 $63.02
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 12 $31.86
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 30 $28.29
85008 <1% 28 $10.94
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 14 $5.64
A9270 Non-covered item or service 0% 752 $0.00
T1015 A visit at a community health center or clinic (one all-in rate) 0% 80 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTANLEY, HOLLY (CFO-CO-INTERIM CEO)